Tinghe Yu

7PUBLICATIONS
5CO-AUTHORS
Econometric and statistical methodsPharmaceutical delivery technologiesLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 09, 2026
Evaluations of Dose-effect Curves and Half-maximal Effective Doses Using the Four-parameter Logistic Model: When are Results Reliable?

|May 15, 2024
Intracellular Pharmacokinetics of Activated Drugs in a Prodrug-Enzyme-Ultrasound System: Evaluations on ZD2767P+CPG2+US.

Tinghe Yu, Xinya Li, Tianran Yu

|Feb 07, 2024
Clinical Trials of High-intensity Focused Ultrasound for Cancer: Concerns Arising from Low Post-Hoc Power.

Tinghe Yu, Xinya Li

|Nov 17, 2022
Ultrasonically Enhanced ZD2767P-Carboxypeptidase G2 Deactivates Cisplatin-Resistant Human Lung Cancer Cells.

Qianfen Liu, Xinya Li, Yuanyuan Luo

|Oct 14, 2022
IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis.

Houmei Wang, Yuanyuan Luo, Rui Ran

|Apr 18, 2020
Ultrasound Enhances ZD2767P-Carboxypeptidase G2 against Chemoresistant Ovarian Cancer Cells by Altering the Intracellular Pharmacokinetics of ZD2767D.

Qianfen Liu, Xiaocui Zhong, Ying Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Houmei Wang

1 joint publications

Qianfen Liu

1 joint publications

Xinya Li

1 joint publications

Yuanyuan Luo